A. Niesen

597 total citations
22 papers, 434 citations indexed

About

A. Niesen is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, A. Niesen has authored 22 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in A. Niesen's work include Radiopharmaceutical Chemistry and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Medical Imaging Techniques and Applications (4 papers). A. Niesen is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Medical Imaging Techniques and Applications (4 papers). A. Niesen collaborates with scholars based in Germany, United States and Canada. A. Niesen's co-authors include Richard P. Baum, A. Hertel, G. Hör, Ragupathy Madiyalakan, Birgit C. Schultes, Carmelo Anile, G Galli, Maria Lucia Calcagni, Alessandro Giordano and Silvia Taralli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of neurosurgery.

In The Last Decade

A. Niesen

20 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Niesen Germany	11	271	104	96	75	73	22	434
M. Casi Italy	9	262 1.0×	70 0.7×	118 1.2×	72 1.0×	61 0.8×	16	403
Li-Na Zhou China	8	128 0.5×	165 1.6×	63 0.7×	25 0.3×	196 2.7×	9	435
Xiao-Guang Zhao United States	9	274 1.0×	51 0.5×	145 1.5×	83 1.1×	76 1.0×	11	455
Maxime Fontanilles France	11	53 0.2×	20 0.2×	226 2.4×	90 1.2×	133 1.8×	31	480
Rajiv Desai United States	8	48 0.2×	46 0.4×	106 1.1×	18 0.2×	78 1.1×	12	264
Edward V. Colapinto United States	11	252 0.9×	40 0.4×	46 0.5×	43 0.6×	90 1.2×	13	434
Renata Ferri Italy	10	32 0.1×	95 0.9×	19 0.2×	39 0.5×	127 1.7×	11	381
Pavel Fadrus Czechia	14	44 0.2×	145 1.4×	170 1.8×	41 0.5×	474 6.5×	40	780
R. Adam Smith United States	11	211 0.8×	45 0.4×	69 0.7×	87 1.2×	101 1.4×	19	441
Jeffrey P. Brousal United States	5	91 0.3×	57 0.5×	24 0.3×	80 1.1×	261 3.6×	6	463

Countries citing papers authored by A. Niesen

Since Specialization

Citations

This map shows the geographic impact of A. Niesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Niesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Niesen more than expected).

Fields of papers citing papers by A. Niesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Niesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Niesen. The network helps show where A. Niesen may publish in the future.

Co-authorship network of co-authors of A. Niesen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Niesen. A scholar is included among the top collaborators of A. Niesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Niesen. A. Niesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palmedo, H., Hojjat Ahmadzadehfar, S. Eschmann, et al.. (2023). Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with²²³Ra: PARABO, a Prospective, Noninterventional Study. Journal of Nuclear Medicine. 64(9). 1392–1398. 3 indexed citations

Palmedo, H., S. Eschmann, A. Niesen, et al.. (2022). Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study. Nuklearmedizin - NuclearMedicine. 61(2). 179–179. 1 indexed citations

Palmedo, H., Hojjat Ahmadzadehfar, S. Eschmann, et al.. (2021). 594P Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study. Annals of Oncology. 32. S641–S641. 1 indexed citations

Calcagni, Maria Lucia, G Galli, Alessandro Giordano, et al.. (2011). Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading. Clinical Nuclear Medicine. 36(10). 841–847. 90 indexed citations

Baum, Richard P., et al.. (2007). Are timing of chemoradiation and early therapy response as detected by PET prognostic factors of a multimodality treatment approach for NSCLC stage III? (LUCAS-MD). Journal of Clinical Oncology. 25(18_suppl). 7532–7532. 2 indexed citations

Hamm, Klaus, Gunnar Surber, Reinhard Würm, et al.. (2004). Stereotactic radiation treatment planning and follow-up studies involving fused multimodality imaging. Journal of neurosurgery. 101(Supplement3). 326–333. 16 indexed citations

Baum, Richard P., et al.. (2004). Peptidrezeptorvermittelte Radiotherapie (PRRT) neuroendokriner Tumoren. Der Onkologe. 10(10). 1098–1110. 18 indexed citations

Surber, Gunnar, Gabriele Kleinert, A. Niesen, et al.. (2004). STEREOTACTIC TREATMENT PLANNING USING FUSED MULTI-MODALITY IMAGING. 3–10. 2 indexed citations

Baum, Richard P., et al.. (2003). Molecular Whole-Body Cancer Staging Using Positron Emission Tomography: Consequences for Therapeutic Management and Metabolic Radiation Treatment Planning. Recent results in cancer research. 162. 195–202. 30 indexed citations

10.

Schultes, Birgit C., et al.. (1998). Anti-idiotype induction therapy: anti-CA125 antibodies (Ab 3 ) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab 1 ). Cancer Immunology Immunotherapy. 46(4). 201–212. 65 indexed citations

11.

Dierks, Thomas, David E.J. Linden, A. Hertel, et al.. (1998). Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease. Psychiatry Research Neuroimaging. 84(1). 27–35. 34 indexed citations

12.

McQuarrie, S.A., R. P. Baum, A. Niesen, et al.. (1997). Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients. Nuclear Medicine Communications. 18(9). 878–886. 20 indexed citations

13.

Krause, Bernd J., et al.. (1997). Human monoclonal antibody99mTc-88BV59: Detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment. European Journal of Nuclear Medicine and Molecular Imaging. 24(1). 72–75. 5 indexed citations

14.

Baum, R. P., et al.. (1995). IMMUNOLOGICAL PROFILE OF PATIENTS WITH OVARIAN-CANCER UNDER IMMUNOSTIMULATION WITH MURINE MONOCLONAL-ANTIBODIES. International Journal of Oncology. 6(4). 853–8. 1 indexed citations

15.

Kiefer, Jan, et al.. (1994). [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].. PubMed. 42(9). 546–52. 2 indexed citations

16.

Baum, R. P., A. Niesen, A. Hertel, et al.. (1994). Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma. Cancer. 73(S3). 1121–1125. 58 indexed citations

17.

Baum, R. P., A. Niesen, A. Hertel, et al.. (1994). Initial clinical results with technetium-99m-labeled ll2 monoclonal antibody fragment in the radioimmunodetection of b-cell lymphomas. Cancer. 73(S3). 896–899. 29 indexed citations

18.

McQuarrie, S.A., et al.. (1994). A pharmacokinetic comparison of murine and chimeric forms of the 99mTc-labelled 174H.64 monoclonal antibody.. PubMed. 38(4 Suppl 1). 140–4. 1 indexed citations

19.

Adams, Stefan, Jan Kiefer, A. Niesen, et al.. (1993). A Novel Technetium-99M Labeled Monoclonal Antibody (174H.64) For Staging Head and Neck Cancer by Immuno-Spect. Acta Oncologica. 32(7-8). 747–751. 17 indexed citations

20.

Baum, Richard P., A.A. Noujaim, Volker Moebus, et al.. (1993). Clinical Course of Ovarian Cancer Patients Under Repeated Stimulation of HAMA Using MAb OC125 and B43.13. Hybridoma. 12(5). 583–589. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact